Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations

Laia Sans-Atxer,1 Dominique Joly2 1Department of Nephrology, Hospital del Mar, Institut Mar for Medical Research, Barcelona, Spain; 2Faculty of Medicine, Université Paris-Descartes, Assistance Publique-Hôpitaux de Paris, Service de Néphrologie, Hôpital Necker-Enfants Malade...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sans-Atxer L, Joly D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2018-01-01
coleção:	International Journal of Nephrology and Renovascular Disease
Assuntos:	Autosomal dominant polycystic kidney disease ADPKD treatment Tolvaptan
Acesso em linha:	https://www.dovepress.com/tolvaptan--in-the-treatment-of-autosomal-dominant-polycystic-kidney-di-peer-reviewed-article-IJNRD
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!